NCT04894409View on ClinicalTrials.gov

Evaluation of Silver Nanoparticles for the Prevention of COVID-19

NACompletedINTERVENTIONAL
Enrollment

231

Participants

Timeline

Start Date

April 24, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

September 29, 2020

Conditions
Coronavirus Disease 2019 (COVID-19)
Interventions
DEVICE

Mouthwash and nose rinse with the AgNPs solution

"The experimental group was instructed to do mouthwash and nose rinse with the AgNPs solution for the prevention of SARS-CoV-2 infection in health workers"

DEVICE

Mouthwashes and nose rinse in a conventional way

The control group was instructed to do mouthwashes and nose rinse in a conventional way

Trial Locations (1)

22310

Tijuana General Hospital, Tijuana

All Listed Sponsors
collaborator

Bionag SAPI de CV

UNKNOWN

collaborator

General Hospital Tijuana

UNKNOWN

lead

Cluster de Bioeconomia de Baja California, A.C

OTHER

NCT04894409 - Evaluation of Silver Nanoparticles for the Prevention of COVID-19 | Biotech Hunter | Biotech Hunter